How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System

from Rx for Biotech · host Podcast Host Chris Leidli

Our guest for this podcast episode is Mike Kelly, President & CEO of NervGen Pharma. NervGen is a clinical-stage biotech company at the forefront of developing treatments that empower the nervous system to repair itself following damage from injury or disease.

Episode metadata supplied by the publisher feed · Published Jul 9, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

How NervGen is Developing Novel Treatments to Repair Damage to the Nervous System

0:00 20:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 20 minutes long.

When was this Rx for Biotech episode published?

This episode was published on July 9, 2024.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!